NEW YORK (GenomeWeb News) – Genedata and Bayer Schering Pharma have entered into a multi-year collaboration to develop and use Genedata's Biologics Data Platform at Bayer Schering locations, the companies said today.

Under the agreement, BDP will support biologics data management and analysis at Bayer Schering R&D sites in Europe and the US, which are developing protein-based therapeutics for diseases such as cancer, hemophilia, and multiple sclerosis.

Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.